← Back to Search

Behavioral Intervention

Mobile App + BP for Opioid Abuse

N/A
Waitlist Available
Led By Gail Herrine, MD
Research Sponsored by Jessica Morgan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up first 7 days following discharge
Awards & highlights

Study Summary

Background: Cesarean delivery is one of the most common obstetric procedures experienced among women who are pregnant.1 Women with Cesarean deliveries have a higher rate of peripartum opioid prescriptions and persistent opioid use compared to those with vaginal deliveries.2 Since 2002, prescription opioid use and misuse has significantly increased among women, including those who are pregnant, showing over 31% increase in past-month heroin use among women of childbearing age.3 This indicates the importance of focusing on maternal population for prescribed opioid medication management during the immediate postpartum period to prevent long-term persistent opioid misuse. Few evidence-based approaches are available to remotely manage prescription opioid use post-discharge.4 Recent advances in mobile technology have made it possible to monitor behavior and maintain communication in near real-time, long after patients are discharged from their surgical procedures.5-7 Using a virtual platform via use of mobile technology offers potential for sustainable implementation of a behavioral intervention and patient-provider communication even during the COVID-19 pandemic.8 Continuous Precision Medicine (CPM™; Research Triangle Park, NC) has developed a mobile app to overcome these barriers for tracking pain and pain medication use among post-surgery patients and tested the logistical and technological feasibility in postpartum patients at Temple OB/GYN. Collectively, our team brings expertise and collaborations between Temple University Hospital, RTI International, and CPM for the following Specific Aims: Aim 1: To examine the preliminary impact of the CPM mobile app to reduce the use of opioids among women post-Cesarean surgery Hypothesis 1: Patients using the CPM application will use fewer Morphine Milligram Equivalents (MME) compared to the blister package group. Aim 2: To establish correlates of pain medication use among women post-Cesarean surgery to estimate the appropriate recommendable dosages per model. Hypothesis 2: Structural and intermediary social determinants such as younger age, lower socioeconomic status, violence and trauma exposure, substance use disorder, and mental and physical health issues will be associated with more opioid medication use.

Eligible Conditions
  • Opioid Abuse

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~first 7 days following discharge
This trial's timeline: 3 weeks for screening, Varies for treatment, and first 7 days following discharge for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Morphine Milligram Equivalents (MME) Used
Secondary outcome measures
Pain Scores

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Mobile App OnlyExperimental Treatment1 Intervention
Patients use a mobile application.
Group II: Mobile App + BPExperimental Treatment1 Intervention
Patients use a mobile application in addition to electronic monitoring blister packs for pain medications.
Group III: BPActive Control1 Intervention
Patients' pain medication is in electronic monitoring blister packs.
Group IV: ControlActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CPMRx
2021
N/A
~100

Find a Location

Who is running the clinical trial?

Jessica MorganLead Sponsor
Temple UniversityOTHER
296 Previous Clinical Trials
82,695 Total Patients Enrolled
Gail Herrine, MDPrincipal InvestigatorTemple University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
New Jersey
How old are they?
18 - 65
What site did they apply to?
Temple University
What portion of applicants met pre-screening criteria?
Did not meet criteria
~26 spots leftby Apr 2025